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ABSTRACT 
Aims/hypothesis: Homeodomain transcription factors play an important role in the 
regulation of pancreatic islet function. In previous studies we determined that Alx3, an 
aristaless-type homeoprotein, is expressed in islet cells, binds to the promoter of the 
insulin gene, and regulates its expression. The purpose of the present study was to 
investigate the functional role of Alx3 in pancreatic islets and its possible involvement 
in the regulation of glucose homeostasis in vivo. 
Methods: Knockout mice lacking Alx3 were used. Glucose and insulin tolerance tests 
were carried out, and serum insulin concentrations were determined. Isolated islets were 
used to test insulin secretion and gene expression. The pancreatic islets were studied 
also by both confocal and conventional microscopy. 
Results: Alx3 deficiency results in increased blood glucose levels and impaired glucose 
tolerance in the presence of normal serum insulin concentrations. Insulin, glucagon and 
glucokinase expression are reduced in Alx3-null pancreatic islets. Reduced insulin 
content is reflected by decreased insulin secretion from isolated islets. Alx3-deficient 
islets also show increased apoptosis, and morphometric analyses indicate that they are 
on average of smaller size than islets from control mice. Alx3 deficiency results in 
reduced beta cell mass. Finally, mature Alx3-null mice develop age-dependent insulin 
resistance due to impaired peripheral insulin receptor signalling. 
Conclusions/interpretation: Alx3 participates in the regulation of the expression of 
essential genes for the function of pancreatic islets, and its deficiency alters the 
regulation of glucose homeostasis in vivo. We suggest that Alx3 constitutes a potential 
candidate to consider in the etiopathogenesis of diabetes mellitus. 
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Keywords: Homeodomain, transcription, aristaless, glucokinase, glucagon, insulin 
secretion, insulin resistance, apoptosis. 
 
Abbreviations: ChIP, chromatin immunoprecipitation; GCK, glucokinase; HBSS, 
Hank´s balanced salt solution. 
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 Increased death of insulin-producing beta cells in pancreatic islets leading to 
insulin deficiency and hyperglycaemia constitutes a hallmark of diabetes mellitus. 
Animal studies have identified a number of defects associated with increased apoptosis 
of beta cells, including endoplasmic reticulum stress [1], defects in intracellular 
signalling pathways [2], or mitochondrial dysfunction [3]. The isolated deficiency of 
some transcription factors that regulate islet cell development and function also produce 
beta cell apoptosis [4]. Prominent among these are Beta2 and Pdx1, two important 
regulators of insulin gene expression. In the first case, Beta2-deficient mice exhibit 
massive death of newly formed beta cells [5]. In the second case, beta cell apoptosis is 
due to Pdx1 haploinsufficiency in heterozygote animals [6]. In addition, conditional 
inactivation of Isl1 has revealed increased postnatal islet cell death and diabetes [7]. 
Finally, loss of function of another important transcription factor, HNF1alfa, can induce 
mitochondrial dysfunction and islet cell apoptosis [8]. 
 The importance of these findings is underscored by the observations that in 
humans, mutations in the genes that encode these transcription factors have been 
associated with different forms of diabetes. Thus, mutations in BETA2 are associated 
with MODY6 [9]; mutations in PDX1 are associated with MODY4 and with late onset 
type 2 diabetes [10, 11]; mutations in ISL1 can be associated with type 2 diabetes [12, 
13]; and mutations in HNF1alfa are causative of MODY3, the most common type of 
monogenic diabetes [14]. 
 Some of these transcription factors regulate complex transcriptional programs of 
gene expression by acting on pancreatic cell specific target gene networks [15, 16]. 
Furthermore, in combination with other transcription factors present in mature cells, 
they interact coordinately on the insulin gene promoter to regulate insulin gene 
expression [4, 17]. Thus, the integrity of transcription factors involved in the regulation 
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of insulin gene expression appears to be important for preventing islet beta cell 
dysfunction leading to diabetes. 
 Previous studies indicated that the aristaless-type homeodomain protein Alx3 
[18] is expressed in glucagon-, somatostatin- and insulin-producing cells of pancreatic 
islets [19]. As those studies identified the insulin gene as the first known target for 
regulation by Alx3, it became important to investigate the role of Alx3 in pancreatic 
beta cell function in vivo. In the present study, we show that Alx3-deficiency in mice is 
associated with impaired glucose homeostasis and with increased cell death in 
pancreatic islets. 
 
Methods 
Alx3-deficient mice. Alx3 mutant mice generated by homologous recombination were 
provided by Dr. Frits Meijlink (Netherlands Institute for Developmental Biology, 
Utrecht, The Netherlands) [20]. Genotyping was performed by PCR as described [20], 
with the exception that the sequence of the forward primer for the wild type allele is 5´-
CATCCCCTCTCCATGCATGTCCCC-3´. Experiments were performed with male 12-
16 week old mice, unless indicated otherwise. Experim ntal protocols involving mice 
were approved by the institutional bioethics committee on research animal care, and 
meet the requirements of Spanish and European Community legislation. 
 
Blood glucose and insulin determinations. Glucose levels were measured from blood 
obtained from the tail vein after an overnight fasting period using an automated 
glucometer (Glucotrend Soft Test System, Boehringer Mannheim, Germany). For 
glucose tolerance tests, after measuring baseline glucose levels mice were injected 
Page 5 of 42
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 6 
intraperitoneally with glucose (2 g/kg), and blood was tested 15, 60 and 120 minutes 
after the injection. 
For insulin tolerance tests, food was removed 4 hours before the test. Basal 
blood glucose concentrations were measured, and then insulin (Actrapid; Novo Nordisk, 
Bagsvaert, Denmark) was injected intraperitoneally at a dose of 0.75 U/kg. Glucose 
concentrations were measured again at the indicated times after insulin administration. 
Serum insulin was measured using an ELISA assay kit (Crystal Chem Inc., Downers 
Grove, IL, USA). 
 
Immunofluorescence. Pancreases were fixed with 4% paraformaldehyde and cryostat 
sections (10 m) were cut. Primary antibodies used are indicated in Supplementary 
Table 1. Secondary antibodies were: Texas Red anti-guinea pig IgG (Vector 
Laboratories, Burlingame, CA, USA; dilution 1:100), 546-Alexa or 488-Alexa anti-
rabbit (Invitrogen, Carlsbad, CA, USA; 1:500 dilution). A minimum of 16-20 sections 
per pancreas from at least 4 animals of each genotype were analyzed. 
 
TUNEL assays. A commercial ApopTag Plus Peroxidase In Situ Apoptosis Detection 
kit (Millipore) was used. Immunodetection was performed using diaminobenzidine 
staining. The number of immunopositive cells in each islet present in sections separated 
by at least 80 m was counted from digital images using NIH ImageJ software. For 
newborn mice, the entire digestive tract including the pancreas was dissected and 
cryostat sections (10 m) were cut. Apoptotic cells were detected using 
diaminobenzidine staining enhanced with nickel ammonium (dark grey colour). 
Sections were then washed and standard insulin immunoperoxidase staining was 
performed (brown colour). 
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Isolation of pancreatic islets. The pancreas was inflated by injecting 3 ml of HEPES (10 
mmol/l)/Hanks' balanced salt solution (HBSS) buffer containing collagenase NB8 (1.36 
U/ml) (SERVA Electrophoresis GmbH, Heidelberg, Germany) through the bile duct 
using a 30 gauge needle. The pancreas was then removed and digested in collagenase 
solution for 12 minutes at 37°C. After washing in cold HBSS containing 0.5% (wt/vol) 
BSA, islets were purified on a discontinuous gradient formed by a mixture of 
Histopaque 1077 and Histopaque 1119 (Sigma, Madrid, Spain) (7:3 ratio) on the lower 
phase, and HBSS-0.5% (wt/vol) BSA on the upper phase. The islet-enriched interphase 
was aspirated, washed, and individual islets were picked using a micropipette under a 
stereomicroscope. 
 
Glucose-stimulated insulin secretion. Batches of 10 isolated islets of approximately 
similar size were transferred to incubation vials containing pre-gassed (95% O2/5% 
CO2) Krebs-Ringer HEPES bicarbonate buffer and 0.5% (wt/vol) BSA (100 l/islet), in 
the presence of 2.8 mmol/l glucose. After incubation for 1 hour at 37ºC, batch triplicates 
(i.e., three tubes containing 10 islets each) were transferred to a similar solution 
containing either 2.8 mmol/l or 20 mmol/l glucose. After a second 1-hour incubation 
period, supernatants were collected and islets were sonicated in acid-ethanol. Insulin 
was assayed by radioimmunoassay (RI-13K, Millipore).  
 
Liver and muscle extracts. Alx3-deficient mice (32-33 week old) were subjected to 
insulin tolerance tests to identify insulin-resistant animals. Several days later, mice were 
treated intraperitoneally with insulin (0.75 U/kg), and after 15 minutes they were killed. 
A fragment of liver and soleus muscle were immediately frozen in liquid nitrogen, and 
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then homogenized in ice-cold lysis buffer [21]. Extracts were centrifuged at 15,000 g for 
40 minutes at 4°C, and the supernatants were collected and stored at –80°C. 
 
Western immunoblots. Islet lysates were resolved by SDS-PAGE and blotted onto a 
nitrocellulose membrane. The following primary antisera were used: rabbit anti-GCK 
(ab37796, Abcam, Cambridge, MA, USA, 1:500 dilution); rabbit anti-Pdx1 C-terminus 
(provided by Joel Habener, Massachusetts General Hospital, Boston; 1:500 dilution); 
rabbit anti-histone H3 (ab1791, Abcam; 1:5000 dilution); and mouse anti-actin 
monoclonal antibody (clone AC-15, Sigma; 1:10:000 dilution).  
 Liver and muscle extracts were resolved by SDS-PAGE and blotted onto 
BioTrace PVDF membranes (Pall Corporation, Pensacola, FL, USA). Membranes were 
incubated with anti-Akt [21] or anti-phospho-Akt (Ser473; sc-7985, Santa Cruz 
Biotechnology) primary antibodies. 
 Secondary antibodies used were goat anti-rabbit or goat anti-mouse peroxidase-
conjugated (1:5000 dilution) (BioRad, Hercules, CA, USA). Immunoreactive bands 
were visualized by enhanced chemiluminescence (Immobilon Western, Millipore). 
Films were scanned and densitometry measurements of bands were performed using 
NIH ImageJ 1.37b software. 
 
Quantitative RT-PCR. Total RNA from isolated islets was extracted using the Illustra 
RNAspin kit (GE Healthcare Europe GmBH, Barcelona, Spain). Quantitative PCR for 
GLUT2, GCK, Pdx1 and glucagon was performed with TaqMan Assay-on-Demand 
primers and the Taqman Universal PCR Master Mix, No AmpErase UNG (Applied 
Biosystems, Alcobendas, Madrid, Spain). For insulin, somatostatin and IRS-2, SYBR 
green detection was used with Power SYBR Green PCR Master Mix (Applied 
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Biosystems) and the primers indicated in Supplementary Table 2. PCR reactions were 
performed in triplicate in a 7900HT fast real-time PCR system (Applied Biosystems), 
and values were normalized to GAPDH mRNA levels. 
 
Chromatin immunoprecipitation assays. Two independent ChIP assays were performed 
on mouse islets as described [19]. PCR was performed using oligonucleotide primers 
that amplify a fragment of the GCK (nucleotides -256 to -1) [22], or glucagon 
(nucleotides -353 to +7) [23] genes (Supplementary Table 3). PCR conditions were as 
follows: 95 ºC for 5 minutes, followed by 30 cycles of 94 ºC for 30 seconds, 61 ºC for 
30 seconds, and 72 ºC for 30 seconds, after which a 5-minute incubation at 72 ºC 
followed. As a control, we used promoter sequences from the PCK gene as described 
[19]. A third independent ChIP assay was performed and analysed by quantitative PCR 
in triplicate samples. In this case the same PCR primers for GCK and PCK were used. 
 
Morphometric analysis. Cryostat sections (10 m) of pancreases were stained with 
cresyl violet and photographed. The number of islets present in sections separated by at 
least 80 m were counted, and the area of each islet was measured using NIH ImageJ 
1.37b software. For the determination of beta cell mass, the whole pancreases from 
three mice of each genotype were removed, weighed, fixed in 4% paraformaldehyde 
and embedded in paraffin. Longitudinal 10 m thick sections generated every 100 m 
were serially processed for diaminobenzidine immunohistochemistry using guinea pig 
anti- human insulin (Linco Research, St. Charles, MO, USA; 1:100 dilution). Sections 
were counterstained with hematoxylin and photographed on a Nikon 90i microscope. 
The area of the insulin-stained cells as well as the entire area of pancreatic tissue in each 
section was calculated on calibrated digital images using NIH ImageJ software. Beta 
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cell mass was then calculated as the product of pancreatic weight and the fractional beta 
cell area in different sections. A total of 26-29 sections per group were analysed.  
 
Results 
Alx3-deficient mice show impaired glucose homeostasis. The body weight curves of 
Alx3-null and wild type mice were similar (Fig. 1a), but blood glucose levels in fasting 
animals were higher in Alx3-deficient mice (Fig. 1b). Importantly, we observed that 
glucose tolerance is impaired in these mice (Fig. 1c-d). In heterozygote mice, fasting 
blood glucose levels (7.31 + 0.13 mmol/l; n = 6) were also significantly higher that in 
control animals (p<0.005, Student’s t-test). On a glucose tolerance test, the 
hyperglycaemic pattern exhibited by heterozygote mice was indistinguishable from that 
observed in homozygote Alx3-deficient animals (not shown), indicating impaired 
pancreatic islet function due to Alx3 haploinsufficiency. Fasting glycaemia was higher 
in mutant females relative to controls (4.21 + 0.29 mmol/l versus 3.19 + 0.25 mmol/l, 
p<0.05, Student's t-test, n=30 per group). Alx3-deficient females also exhibited 
impaired glucose tolerance (not shown). Serum insulin levels in basal conditions or after 
an injection of glucose were similar in wild type and Alx3-mutant mice, despite the 
observed differences in glucose levels (Fig. 1e-f). These experiments suggest that the 
amount of insulin released in Alx3-deficient mice is not sufficient to lower blood 
glucose levels to values similar to those found in wild type animals.  
 We evaluated glucose-stimulated insulin secretion from isolated islets in vitro. 
Exposure of islets to 20 mmol/l glucose resulted in insulin secretion in wild type and 
mutant mice. However, the values observed in samples corresponding to Alx3-null mice 
were significantly lower than those found in samples from wild type animals (Fig. 2a). 
Measurement of the total insulin content revealed that the amount of hormone in islets is 
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lower in Alx3-deficient mice (Fig. 2b). When insulin secretion values were normalized 
against total insulin content, the percentage of insulin secreted from mutant and wild 
type islets was found to be equivalent (Fig. 2c). These data are consistent with the 
notion that Alx3 deficiency does not affect the mechanisms involved in glucose-
stimulated insulin secretion per se. Rather, decreased secreted insulin appears to be a 
reflection of decreased insulin content. 
 
Altered gene expression and increased apoptosis in Alx3-deficient islets. To investigate 
possible alterations in pancreatic islets, we determined the mRNA levels of GLUT2 and 
GCK, as they constitute the first steps in glucose intake and sensing by beta cells. We 
found that mRNA levels for GLUT2 in islets were similar in Alx3-deficient and in wild 
type mice (Fig. 3a). Immunofluorescence staining (Fig. 3c) and western immunoblot 
(data not shown) confirmed similar levels of expression in both groups. In contrast, we 
detected a significant reduction in the levels of GCK mRNA in Alx3-deficient islets 
(Fig. 3a). This reduction was correlated with a decrease in islet GCK at the protein 
level, as assessed both by western immunoblot (Fig. 3b) and by immunofluorescence 
(Fig. 3c). Furthermore, ChIP assays revealed that in pancreatic islets of wild type 
animals, Alx3 binds directly to the GCK gene promoter (Fig. 3d-e). 
Insulin-I and glucagon mRNA levels were also decreased (Fig. 3a). Decreased 
insulin levels were also observed by immunofluorescence (Fig. 3f) and confirmed by 
western immunoblot (Fig. 3g). By ChIP assay we found that Alx3 occupies the 
glucagon gene promoter in vivo (Fig. 3d). These results were validated by promoter 
reporter assays in transfected cells (Suppl. Fig. 3). Together, our data indicate that Alx3 
regulates the expression of the GCK and glucagon genes. We did not find significant 
differences in the levels of Pdx1 mRNA (Fig. 3a) or protein (Figs. 3b and f). 
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 We investigated whether the observed islet alterations in Alx3-null mice are 
accompanied by increased cell death. In newborn wild type or mutant mice, very few 
apoptotic cells were found by TUNEL assay (Fig. 4b), and no differences were 
observed between both genotypes (Suppl. Fig. 1). In contrast, in adult young mice (15 
weeks old) Alx3-deficient islets showed a significantly higher percentage of apoptotic 
cells as compared with wild type controls (Fig. 4b). In mature mice (36 weeks old) the 
percentage of apoptotic cells remained practically unchanged in the wild type group, but 
in the Alx3-null group apoptotic cells increased significantly as compared to the 
younger animals, indicating a gradual decline with age (Fig. 4b). This was confirmed by 
determining the presence of activated caspase-3, which was present throughout the 
mutant islets (Fig. 4c). To find out whether cell loss was compensated by increased cell 
replication, we determined the number of Ki67-positive islet cells, but observed no 
differences between wild type and Alx3-null mice (Suppl. Fig. 2). 
 These experiments indicate that there is a substantial degree of cell loss in the 
islets of adult Alx3-deficient mice that could have an impact on islet size. To clarify this, 
we performed morphometric analyses that revealed a reduced size of Alx3-deficient 
islets (Fig. 5). The average protein content per islet in mutant mice is reduced by almost 
half relative to that of controls, reflecting a smaller islet size (Fig. 5d). A comparative 
analysis of the distribution of islet sizes in histological sections indicated that Alx3-
mutant mice lack pancreatic islets of the largest sizes (>70,000 m2, Fig. 5f), whereas 
approximately 10% of islets in wild type animals fall within this range. In agreement 
with these observations, beta cell mass was reduced in the pancreases of Alx3-deficient 
mice (Fig. 5e).  
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Age-related insulin resistance in Alx3-deficient mice. In the course of the experiments to 
determine blood insulin concentration after glucose administration described in figure 1, 
we detected one Alx3-deficient mouse within the group of younger animals with an 
abnormally elevated serum insulin concentration (1056.7 pmol/l) 2 hours after glucose 
administration (Fig. 6a; not included in Fig. 1). To explore the possible significance of 
this finding we increased the number of animals tested for serum insulin at that time 
point after glucose injection, but no additional hyperinsulinemic animals were found 
within this group ( ig. 6a). In contrast, within the group of 36-40 week-old animals, 
from a total of 25 Alx3-null mice tested, 28% were found to form a distinct subgroup 
that exhibited significantly increased serum insulin levels (Fig. 6a).  
 Prompted by this finding, we performed insulin tolerance tests to explore the 
possibility that peripheral insulin action in Alx3-deficient mice may be impaired due to 
insulin resistance. We found that insulin administration lowered blood glucose levels in 
both wild type and mutant 12-16 week-old mice to a similar extent, indicating that Alx3 
deficiency does not impair insulin sensitivity at this age (Fig. 6b). Similarly, in the 36-
40 week-old group, we found no statistically significant differences (ANOVA) in 
insulin action on blood glucose levels between wild type and most (71.5%) mutant mice 
(Fig. 6c). However, in this age group, we found that 28.5% Alx3-deficient mice were 
totally unresponsive to insulin (Fig. 6c, dashed line). A similar result was also observed 
in age-matched females (data not show). There was no correlation between the presence 
of insulin insensitivity and weight, which remained within normal values in all animals 
tested. Taken together, these data indicate that Alx3-deficicient mice develop age-
dependent insulin resistance. 
 In an initial effort to investigate the cause of the observed insulin resistance, we 
monitored insulin-induced phosphorylation of Akt in liver and muscle. We found that 
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insulin administration results in Akt phosphorylation in wild type and non-insulin-
resistant Alx3-null mice, but not in insulin-resistant Alx3-mutant mice (Fig. 7), 
indicating that peripheral insulin signalling is compromised in these animals. 
 
Discussion 
 Our work indicates that the main consequences of Alx3 deficiency in pancreatic 
islets are decreased content of insulin and GCK, increased apoptosis, and reduced islet 
size. The effect on insulin is consistent with our previous findings that Alx3 regulates 
insulin gene expression [19]. As a consequence of these defects, the amount of insulin 
released in response to glucose stimulation in vitro is comparatively reduced. 
Importantly, this reduction does not necessarily indicate a defect in the insulin secretory 
machinery per se, a notion supported by the observation that levels of circulating insulin 
in vivo were not found to be reduced in fasting Alx3-deficient mice in basal conditions 
or after a glucose challenge. 
 One possible interpretation of these apparently contrasting results is that the 
mutant islets are overstimulated by the hyperglycaemic environment in vivo to maintain 
blood insulin levels close to normal values in the presence of elevated glucose levels 
[24]. In addition, the observation that Alx3-deficient mice exhibit relatively high blood 
glucose levels in fasting conditions despite normal levels of serum insulin is consistent 
with the existence of a defect in the glucose sensing mechanisms in beta cells, resulting 
in a displacement of the threshold at which glucose concentration elicits the release of 
appropriate amounts of insulin to the circulation. As GCK acts as a glucose sensor in 
beta cells, this notion is in line with our finding of reduced GCK expression in Alx3-null 
mice [25, 26].  
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 The reduced GCK expression associated with Alx3 deficiency is relevant 
because loss of function mutations in GCK in humans are a known cause of MODY2. 
Similarly to Alx3-deficient mice, these patients exhibit chronic mild fasting 
hyperglycaemia in the presence of normal levels of serum insulin, reflecting a resetting 
of their homeostatic control such that increased glucose levels are necessary to elicit 
normal levels of insulin secretion [27-29]. Mouse models of MODY2 by heterozygous 
disruption of the GCK gene are also characterized by mild fasting hyperglycaemia and 
impaired glucose tolerance [25, 30]. Thus, Alx3 deficiency could primarily affect islet 
cell function by a combined effect on both insulin and GCK expression, as our data 
indicate that the GCK gene, as well as the insulin gene [19], is a direct target regulated 
by Alx3 at the transcriptional level. 
 Another important feature of Alx3-deficient islets is the relatively high number 
of apoptotic cells in adult, but not in newborn mice, indicating that Alx3 is important for 
the long term maintenance of islet cell survival. Similar to Alx3, deficiency of other 
transcription factors that regulate insulin gene expression and beta cell function also 
leads to increased beta cell apoptosis and impaired islet function [4]. Increased 
apoptosis in pancreatic islets can lead to decreased b ta cell mass to the point of 
compromising islet cell function [6, 31, 32].  
 The mechanisms by which lack of Alx3 results in islet cell apoptosis are 
currently unknown. Decreased GCK activity can lead to increased apoptosis in islets [3, 
33]. Indeed, GCK has been shown to be associated with the proapoptotic protein BAD, 
which acts as a molecular switch regulating metabolic activity and apoptosis in beta 
cells [34]. Since expression of GCK is reduced in pancreatic islets of Alx3 deficient 
mice, this may well provide a mechanistic explanation for the increased rate of cell 
death observed in these mice. Interestingly, beta cell-specific disruption of the GCK 
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gene may lead to altered islet cell distribution [30]. In Alx3-deficient mice we observed 
altered islet architecture, evidenced by mislocalization of a number of alpha and delta 
cells found scattered throughout the islet core (not shown). Defects in islet architecture 
have often been associated with increased beta cell apoptosis [6, 31]. 
 Nonetheless, lack of Alx3 may lead to apoptosis by other mechanisms that are 
unrelated to GCK expression. In support of this notion, we have observed an increased 
rate of apoptotic cell death associated with Alx3-deficiency in the cranial mesenchyme 
of developing embryos [35], a major site of Alx3 expression during development [18]. 
 The smaller size observed in Alx3-deficient pancreatic islets may be related to 
their relatively high proportion of apoptotic cells, and may contribute to impaired islet 
cell function. This condition may be important even though Alx3-deficient mice do not 
appear to develop high hyperglycaemic values typical of overt diabetes, because if 
increased cell death by apoptosis remains a dominant determinant in Alx3-deficient 
islets, compensation by hyperplasia in response to diabetes-related risk factors such as a 
high fat diet could be compromised. A similar situation has been recently observed in 
Pdx1 haploinsufficient mice [32]. We did not find evidence of increased proliferation in 
islets to compensate for the apoptotic cell loss. Thus, Alx3-deficiency could potentially 
constitute a vulnerability factor for the development of diabetes in response to a 
particular challenge such as an unbalanced diet, an important question that deserves 
further investigation.  
 In young (12-16 weeks old) Alx3-deficient mice, the existence of impaired 
glucose tolerance in the presence of serum insulin levels that were similar to those 
found in control animals was initially suggestive of insulin resistance. However, all 
animals of this age tested for an insulin tolerance test showed normal insulin sensitivity, 
hence our interpretation discussed above that the primary defect in these animals relates 
Page 16 of 42
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 17 
most likely to the islets, and not to the existence of peripheral insulin resistance. In 
contrast, the observations of hyperglycaemia in the presence of increased serum insulin 
levels, impaired insulin tolerance tests, and defective insulin signalling in a significant 
number of Alx3-deficient mice within the 36-40 week old group, clearly indicates the 
development of insulin resistance in an age-dependent manner. It is not clear why only a 
proportion of mice develop insulin resistance, but this could simply be due to the 
progressive nature of this condition. Thus, it remains to be determined whether the 
incidence of insulin resistance in even older Alx3-deficient mice is higher than that 
found in the present study. Conversely, if Alx3-deficient animals exhibit increased 
susceptibility to environmental factors, it is possible that an appropriate challenge such 
as high fat diet could result in increased proportion of insulin resistance, even in 
younger animals. 
 Although insulin resistant Alx3-null mice have impaired insulin signalling 
evidenced by decreased Akt phosporylation in liver and muscle, the ultimate 
mechanism responsible for this defect is unknown. Insulin resistance can develop in 
animals with reduced islet cell mass [36, 37], an observation in line with the notion that 
metabolic alterations in diabetes are the consequence of a primary defect in beta cells 
[38-40]. In any case, it is formally possible that the observed phenotype reflects beta 
cell defects in combination with insulin resistance. 
In summary, our data indicate that Alx3 deficiency alters islet cell function and 
compromises islet cell viability, leading to an impairment of glucose homeostasis. 
Although the alterations observed in this study do not reach the degree of severity 
typical of overt diabetes, it is known that certain mutations, or even common variants of 
some of the genes that encode transcription factors involved in the maintenance of islet 
cell function may increase the risk to develop diabetes [32, 41-43]. Of note, the human 
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ALX3 gene is located in chromosome 1p21-p13, a region that is synthenic with regions 
of rat chromosome 2 and mouse chromosome 3 that have been linked to diabetes by 
quantitative trait loci analysis [44-46]. Therefore, our data support the proposal that 
ALX3 is a putative candidate gene to take into account for predisposition to diabetes. 
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FIGURE LEGENDS 
 
Figure 1. Mild hyperglycaemia and glucose intolerance in Alx3-deficient mice. a) 
Growth rate in terms of body weight of Alx3-deficient and control wild type mice 
monitored between 6 and 36 weeks of life. Circles correspond to wild type mice and 
squares to Alx3-deficient mice. Data represent the mean + s.e.m. of 20-34 animals in 
each group. b) Basal blood glucose concentrations after fasting in wild type and Alx3-
deficient mice. Data from two different age groups are shown. White columns 
correspond to wild type mice and black columns to Alx3-deficient mice. Each column 
represents the mean + s.e.m. of determinations taken from 8-14 animals. *p<0.02, 
Student´s t-test. c-d) Glucose tolerance tests carried out in fasting wild type (circles) or 
Alx3-deficient (squares) mice that received an intraperitoneal injection of glucose (2 
g/kg of body weight). Data from animals of 12-16 weeks of age (c; n = 9 and 5, 
respectively) or 36-40 weeks of age (d; n = 8 and 14, respectively) are shown. Note that 
blood glucose concentrations are significantly higher in mutant than in control animals 
at all times measured, and remained elevated relative to their own basal values for more 
than 2 hours. *p<0.05, **p<0.01 and ***p<0.001 as compared with wild type mice 
(ANOVA); #p<0.05, as compared to basal levels before the glucose injection (Student’s 
t-test). e-f) Serum concentrations of insulin in fasting wild type (circles) or Alx3-
deficient (squares) mice at the indicated times after receiving an intraperitoneal 
injection of glucose (2 g/kg of body weight). Data from mice of 12-16 weeks of age (e; 
n = 6 in each genotype group) or 36-40 weeks of age (f; n = 5 and 6, respectively) are 
shown. In all cases, data represent the mean + s.e.m.  
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Figure 2. Glucose-stimulated insulin secretion and insulin content. In all cases, white 
columns correspond to wild type mice and black columns to Alx3-deficient mice. a) 
Glucose-stimulated insulin secretion from isolated pancreatic islets in vitro. Data are 
expressed as mean + s.e.m. of values obtained from experiments carried out in triplicate. 
Each animal provided islets for one low glucose (2.8 mmol/l) and one high glucose (20 
mmol/l) triplicate (n = 6 for each condition in the case of wild type islets, and 9 for each 
condition in the case of Alx3-null islets). *p<0.05 relative to low glucose control; # 
p<0.01 relative to wild type high glucose values; Student’s t test. b) Insulin content in 
isolated islets from wild type (+/+) and Alx3-deficient (-/-) mice. Data are expressed as 
mean + s.e.m. of values obtained from sample tubes (42 for wild type, and 62 for 
mutant islets) each containing 10 islets. *p<0.01, Student’s t test. c) Glucose-stimulated 
insulin secretion from isolated pancreatic islets in vitro. The graph corresponds to data 
shown in a, but normalized to total insulin content in islets. *p<0.02, **p<0.05, relative 
to low glucose control; Student’s t-test.  
 
Figure 3. Alx3-deficient mice exhibit decreased pancreatic islet glucokinase expression. 
a) Relative levels of mRNA extracted from isolated pancreatic islets of wild type (white 
columns) or Alx3-deficient (black columns) mice, as assessed by quantitative RT-PCR. 
Data represent the mean + s.e.m. of 5-10 independent samples amplified in triplicate 
and normalized to GAPDH. *p=0.025, **p<0.01; Student’s t-test. Abbreviations: Glut2, 
glucose transporter 2; GCK, glucokinase; Ins, insulin; Glu, glucagon; SMS, 
somatostatin; IRS2, insulin receptor substrate 2. b) Western immunoblot showing 
glucokinase (GCK) and Pdx1 expression carried out with extracts of isolated islets from 
wild type (WT) or Alx3-deficient (KO) mice. Histograms on the bottom represent 
densitometric analysis performed to quantify the relative intensity of GCK- and Pdx1-
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immunoreactive bands detected by Western immunoblot. Results are expressed as a 
percentage of increment of densitometry measurements of GCK or Pdx1 bands (in 
arbitrary units) relative to the intensity of the corresponding actin or histone H3 bands. 
Quantification from separate blots (n = 8 animals per group) is shown. *p<0.05; n.s., not 
significant; Student’s t-test. c) Representative examples of sections from the pancreases 
of wild type (top) or Alx3-deficient (bottom) mice processed for Glut2 and GCK 
immunostaining and analyzed by confocal microscopy. d) ChIP assay showing PCR 
amplification of glucokinase (GCK) or glucagon (Glu) chromatin immunoprecipitated 
(IP) with anti-Alx3 antiserum or with control nonimmune rabbit serum (NRS) from 
pancreatic islets isolated from wild type mice. PCR amplification was not obtained with 
primers corresponding to the control PCK gene. The panel depicts results from one of 
two independent experiments yielding similar data. e) Results from an additional ChIP 
experiment analysed by quantitative PCR carried out in triplicate. Data represent fold 
enrichment relative to input. For each one of the ChIP assays shown in e and d, 
approximately 1500 islets from 10-11 animals were used. f) Immunofluorescence 
images taken from sections of pancreases processed for Pdx1 (green) and insulin (red) 
immunoreactivity and analyzed by confocal microscopy. Sections from wild type and 
Alx3-null islets mice were strictly processed in parallel for immunostaining, and 
photographs were taken with identical configuration settings for the confocal 
microscope and the digital camera. The asterisk denotes a staining artefact. g) Western 
immunoblot showing insulin expression in extracts of isolated islets from three wild 
type (WT) or three Alx3-deficient (KO) mice. Samples were resolved using a 4-20% 
precast gel (Bio-Rad) and a guinea pig anti-insulin antiserum (1:1000 dilution; Linco 
Research, St. Charles, Missouri, USA) .  
 
Page 26 of 42
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 27 
Figure 4. Alx3-deficient islets exhibit increased apoptosis. a) Images of islets from 
sections of pancreases from 36 week old wild type and Alx3-deficient mice processed 
for TUNEL staining and counterstained with hematoxylin. Insets indicated on each 
section are shown at higher magnification on the bottom panels. Examples of TUNEL-
positive nuclei are indicated by arrowheads. b) Quantification of the percentage of 
TUNEL positive cells in islets of wild type (white columns) or Alx3-mutant (black 
columns) mice of different ages. For newborn mice, digital images (see Supplementary 
Figure 1) from two wild type and three Alx3-null mice (33-40 sections per genotype) 
were used for quantification. For adult mice, a total of 31-50 islets from 2 different mice 
in each genotype and age were used. Data represent the mean + s.e.m. *p<0.0001, 
Student's t-test. c) Immunofluorescence images taken from sections of pancreases 
processed for insulin (red) and activated caspase-3 (green) immunoreactivity. Note that 
activated caspase-3 immunoreactivity is only evident in the Alx3-mutant islet. 
 
Figure 5. Reduced size of pancreatic islets in Alx3-deficient mice. a) Representative 
examples of cresyl violet-stained sections of pancreases used for morphometric 
analyses. b) Representative examples of insulin immunostained sections of pancreases 
used for calculation of the beta cell mass. c) Islet size determined in sections similar to 
those shown in a. A total of 337 islets from three wild type animals and 309 islets from 
three Alx3-deficient mice were counted. Data are represented as box-and-whisker plots 
showing median values, first and third quartiles, as well as outliers. Statistical analysis 
indicated that differences between wild type and Alx3-deficient islets are significant 
(p<0.01; Mann-Whitney U-test). d) Relative protein content per islet as determined by 
Bradford assays of lysates of groups of isolated islets (70-130 islets per lysate) from 5 
wild type and 8 Alx3-deficient mice. *p<0.05, Student’s t-test. e) Beta cell mass 
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calculated from sections of pancreases immunostained for insulin. **p<0.0001, 
Student´s t-test. Data in c and d are mean + s.e.m. f) Distribution of islets according to 
size. White columns correspond to wild type mice and black columns to Alx3-deficient 
mice. Note the absence of islets of the largest sizes (>70 m2 x 103) in the pancreases 
from Alx3-null mice. Statistical analysis indicated that differences between the 
distribution of wild type and Alx3-deficient islets are significant (p<0.001; 2 test). 
 
Figure 6. Alx3-deficient mice develop age-dependent insulin resistance. a) Serum 
insulin levels of individual wild type or Alx3-deficient mice of two different age groups, 
detected 2 hours after an intraperitoneal injection of glucose (2 g/kg of body weight) 
administered after an overnight fasting period. Note the presence of only one high value 
for serum insulin in the Alx3-mutant 12-16 week old group, and several (28%) in the 
Alx3-mutant 36-40 week-old mutant mice. b and c) Insulin tolerance tests showing 
relative changes in blood glucose concentrations observed in wild type (circles) or Alx3-
deficient (squares) mice after intraperitoneal administration of insulin. Data from 
animals of 12-16 weeks of age (b) or 36-40 weeks of age (c) are shown, and represent 
the mean + s.e.m. In b, six wild type and seven mutant mice were used. In c, the data 
from seven wild type animals were used to plot the graph, but 11 additional wild type 
mice were tested yielding similar results. In the 36-40 week age group, a total of 21 
Alx3-mutant mice were tested. In six of these, blood glucose levels were not decreased 
by the administration of insulin, represented in the graph by a dashed line. *p<0.05, 
**p<0.01 and ***p<0.001 as compared with wild type mice (ANOVA). 
 
Figure 7. Alx3-deficient mice develop impaired insulin signalling in peripheral tissues. 
a) Western immunoblots showing phophorylated (P-) and total Akt in liver or muscle 
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extracts from wild type (WT) or Alx3-deficient non insulin resistant (nir-KO) or insulin 
resistance (ir-KO) mice. Each lane represents extracts from the same animal. b-c) 
Results of densitometric measurements for quantification of the intensity of P-Akt 
bands relative to that of total Akt bands in liver (b) and muscle (c). Black columns 
correspond to samples from animals that have been treated with insulin (0.75 U/kg i.p.), 
and white columns to those from control non-treated mice. Three mice were used for 
each condition. Data represent mean + s.e.m. *p<0.05; **p<0.01; Student's t-test.  
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






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Supplementary Table 1. Primary antibodies used for immunofluorescence 
Antibodies 
 
Provider Dilution 
Guinea pig anti-insulin Linco Research, St. Charles, Missouri, USA 1:100 
Guinea pig anti-glucagon Linco Research, St. Charles, Missouri, USA 1:100 
Rabbit anti-somatostatin Millipore, Billerica, MA, USA 1:500 
Rabbit anti-Pdx1 C-terminus Dr. Joel Habener, Massachusetts General Hospital, Boston, USA 1:500 
Rabbit anti-glucokinase Santa Cruz Biotechnology, Santa Cruz, CA, USA 1:250 
Rabbit anti-GLUT2 Alpha Diagnostic International, San Antonio, TX, USA 1:500 
Rabbit anti-cleaved Caspase-3 Cell Signalling Technology, Beverly, MA, USA 1:200 
Rabbit anti Ki67 Abcam, Cambridge, MA, USA 1:250 
 
 
 
 
Supplementary Table 2. Oligonucleotide primers used in quantitative RT-PCR experiments 
 Forward Reverse 
Insulin-1 5´- TAGTGACCAGCTATAATCAGA -3´ 5´- AACGCCAAGGTCTGAAGGTCC -3´ 
Insulin-2 5´- CCCTGCTGGCCCTGCTCTT -3´ 5´- GGTCTGAAGGTCACCTGCT -3´ 
Somatostatin 5´- CGTCAGTTTCTGCAGAAGTC -3´ 5´- CAGGGTCAAGTTGAGCATCG -3´ 
IRS2 5´- ACCGCGCACTCACCGACTTG -3´ 5´- GTCACCGACGGCTGTTCGCA -3´ 
 
 
 
 
Supplementary Table 3. Oligonucleotide primers used for PCR in ChIP experiments 
 Forward Reverse 
Glucokinase 5´- GTGATAGGCACCAAGGCACTGAC -3´ 5´- CGGTGCTTCTGTTCCAACCAGG -3´ 
Gucagon 5´- CCAAATCAAGGGATAAGACCCTC -3´ 5´- AAGCTCTGCCCTTCTGCACCAG -3´ 
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Supplementary Figure 1. Representative pancreatic islets (left panels) and intestine (right panels) from 
sections obtained from Alx3-deficient (top panels) or wild type (bottom panels) mice. Sections were 
processed for insulin (brown) and TUNEL (dark grey) double immunostaining. For each genotype, both 
pancreas and intestine are part of the same sections, so that apoptotic cells normally present in the 
intestine served as positive controls for TUNEL. Examples of apoptotic cells in the intestine are indicated 
by arrows. No apoptotic cells are shown in islets, as they were observed only rarely and were not more 
abundant in Alx3-deficient than in wild type mice (0.17 + 0.03 and 0.12 + 0.03 cells/islet, respectively). 
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Supplementary Figure 2. Evaluation of cell proliferation. a-d, Pancreatic islets from sections processed 
by immunofluorescence staining for the proliferation marker Ki67 (red), and counterstained with DAPI 
(blue). Images depict islets from young (14 weeks) wild type (a-b) or Alx3-deficient (c-d) mice. The 
presence of Ki67-positive cells is indicated by arrows. As a positive control for proliferating cells we 
used sections of neonatal mouse intestine processed in parallel (e-f), as most pancreatic islets examined 
did not show any Ki67-positive cells. Examples of proliferating cells in this tissue are indicated by 
arrows, whereas non-proliferating cells are also evident. Most islets examined did not show proliferating 
cells (not shown). Quantification of the total number of Ki67-positive cells in islets yielded the following 
results (mean + s.e.m.): Islets from young wild type mice: 0.02 + 0.01, n = 46; islets from young Alx3-
null mice: 0.06 + 0.02, n = 48; islets from mature wild type mice: 0.03 + 0.02, n = 39; islets from mature 
Alx3-null mice: 0.01 + 0.01, n = 26. Evaluation of the data by Student's t-test did not reveal any statistical 
significance between wild type and Alx3-deficient groups. 
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Supplementary Figure 3. Alx3 transactivates the glucagon and glucokinase (GCK) promoters in 
transfected cells. Reporter plasmids for glucagon and GCK promoters were newly constructed by PCR 
using mouse genomic DNA as a template, and the resulting products were cloned into the XhoI and 
HindIII sites of the luciferase reporter plasmid pGL3-Basic (Promega; Madison, WI, USA). Relative to 
their respective transcriptional initiation sites, the glucagon promoter spans nucleotides -370 to +16, and 
the GCK promoter spans nucleotides -280 to +30. The insulin promoter corresponds to a fragment of the 
rat insulin I gene spanning nucleotides -410 to +34. This was used as a negative control, as it is known 
that Alx3 does not transactivate the insulin promoter unless it is in the presence of the transcription 
factors E47 and Beta2 (Mirasierra and Vallejo, 2006). Transfections ere carried out in Hela cells seeded 
at a density of 100.000 cells per well into 24-well plates. Cells were transfected with TrasFectin Lipid 
Reagent (Bio-Rad, Barcelona, Spain) using 0.5-1 g of reporter plasmid and 250 ng of the expression 
vector pcDNA3-Alx3 (+) of the control plasmid pcDNA3 (-). In all cases the total amount of transfected 
DNA was kept constant. Luciferase activity was measured 48 hours after transfection using a commercial 
assay system (Promega). The Rous sarcoma virus enhancer reporter plasmid RSV-Luc was used as an 
independent standard for normalization, and efficiencies were corrected by using the Renilla luciferase 
assay system (Promega). Data represent mean + s.e.m. of three independent experiments carried out in 
duplicate. 
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